Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Acne vulgaris - Pipeline Insight, 2021

US$ 2,000.00

... clients within 5 Days 'Acne Vulgaris - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Acne Vulgaris development. The report provides ...

June 2021 70 pages

Angina pectoris - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Angina (Angina Pectoris) The report also ...

June 2021 60 pages

Cachexia - Pipeline Insight, 2021

US$ 2,000.00

... clients within 48 Hours 'Cachexia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cachexia development. The report provides detailed ...

June 2021 80 pages

Diabetic foot ulcer - Pipeline Insight, 2021

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Diabetic Foot Ulcers The report also ...

June 2021 80 pages

Pruritus - Pipeline Insight, 2021

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Pruritus - Pipeline Insight, 2019 The report also ...

June 2021 90 pages

Vulvovaginal candidiasis - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Vulvovaginal Candidiasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vulvovaginal Candidiasis development. The report provides ...

June 2021 60 pages

Post-traumatic stress disorders - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Post-Traumatic Stress Disorder (PTSD) The report also ...

June 2021 60 pages

Urea cycle disorders - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Urea Cycle Disorders The report also ...

June 2021 60 pages

Adenoid cystic carcinoma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 Hours DelveInsight’s, “Adenoid cystic carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipe...

June 2021 60 pages

Allergic rhinitis - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Allergic rhinitis - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline...

June 2021 90 pages

Diffuse large B cell lymphoma - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Diffuse large B cell lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 80+ companies and 8...

June 2021 60 pages

Migraine - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Migraine - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in...

June 2021 60 pages

Pancreatic Cancer - Pipeline Insight, 2021

US$ 3,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Pancreatic Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipelin...

June 2021 60 pages

Respiratory syncytial virus infections - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Respiratory syncytial virus infections - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ compan...

June 2021 60 pages

U.S. Online Pharmacy Market - Industry Outlook & Forecast 2021-2026

US$ 3,500.00

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in U.S. Online Pharmacy Market Report The U.S. online pharmacy market by revenue is expected to grow at a CAGR of approx....

June 2021 152 pages

Anorexia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Anorexia - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in An...

June 2021 60 pages

Blastic Plasmacytoid Dendritic Cell Neoplasm - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 Hours DelveInsight’s, “Blastic Plasmacytoid Dendritic Cell Neoplasm - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ c...

June 2021 60 pages

Glabellar lines - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Glabellar lines - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drug...

June 2021 60 pages

Gonorrhoea - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Gonorrhoea - Pipeline Insight, 2021,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs i...

June 2021 60 pages

Hypercholesterolaemia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Hypercholesterolaemia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipel...

June 2021 60 pages

Hypertrophic cardiomyopathy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Hypertrophic cardiomyopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ p...

June 2021 60 pages

Malaria - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Malaria - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in M...

June 2021 60 pages

Nosocomial pneumonia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Nosocomial pneumonia - Pipeline Insight, 2021,” report provides comprehensive insights about 13+ companies and 15+ pipeli...

June 2021 60 pages

Obesity - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Obesity - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in O...

June 2021 60 pages

Relapsing-remitting multiple sclerosis - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Relapsing-remitting multiple sclerosis - Pipeline Insight, 2021,” report provides comprehensive insights about 25+ compan...

June 2021 60 pages

Richter’s syndrome - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 Hours DelveInsight’s, “Richter’s syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline d...

June 2021 60 pages

Scars - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Scars - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Sca...

June 2021 60 pages

Tuberculosis - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Tuberculosis - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs...

June 2021 60 pages

Clinical Trial Market, Global Forecast Impact of COVID-19, Industry Trends by Phases, Study Design, Region, Opportunity Company Overview, Revenue

US$ 2,290.00

The clinical trial is a human medical study designed to test the safety and effectiveness of drugs, therapeutic products, and devices before they are ultimately launched in the market. Around the worl...

June 2021 135 pages

Global Injectable Drugs Market (2021 Edition) – Analysis By Molecule (Small, Large), Delivery (Prefilled, Infusion, Others), Product, By Region, By Country: Market Insights and Forecast with Impact of Covid-19 (2021-2026)

US$ 2,200.00

EXECUTIVE SUMMARY The Global Injectable Drugs Market was valued at USD 414.88 Billion in the year 2020. Increasing prevalence of diseases such as diabetes, cancer and auto-immune disorders like rheum...

May 2021 230 pages

Global mRNA Vaccine and Therapeutics Market – Analysis By Product, End User, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of Covid-19 (2021-2030)

US$ 2,000.00

EXECUTIVE SUMMARY The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in c...

May 2021 220 pages

Global Psychedelic Drugs Market (2021 Edition) – Analysis By Drug, Route of Administration, Distribution Channel, By Region, By Country: Market Insights, Pipeline Drugs and Forecast with Impact of Covid-19 (2021-2026)

US$ 2,200.00

EXECUTIVE SUMMARY The Covid-19 pandemic has restricted the movement of people, confining them in their homes, caused severe trauma and stress in the form of sadness and loneliness and has affected th...

May 2021 260 pages

U.S. Hepatitis Vaccines Market – Growth, Demand, Trends, Opportunity, Forecasts (2021 – 2027)

US$ 1,500.00

The United States hepatitis vaccines market is projected to boost over the forecast period of 2021 to 2027. This new market report provides a comprehensive analysis of the fast-evolving, high-growth...

May 2021 70 pages

U.S. Influenza (Flu) Vaccines Market – Growth, Demand, Trends, Opportunity, Forecasts (2021 – 2028)

US$ 2,500.00

The United States influenza vaccines market size to cross US$ 5.5 Billion by 2028. This new market report presents an inclusive study of the entire United States influenza vaccines market. The report...

May 2021 205 pages

Investigation Report on China's Abiraterone Market 2021-2025

US$ 2,600.00

Abiraterone is a CYP17 inhibitor, which is mainly clinically used to treat prostate cancer patients. Its product ZYTIGA was developed by Janssen-Cilag International NV(a subsidiary of Johnson & Johnso...

May 2021 50 pages

Investigation Report on China's Butylphthalide Market 2021-2025

US$ 2,600.00

Butylphthalide, developed by CSPC Enbipu Pharmaceutical Co. Ltd is used to treat mild to moderate acute ischemic stroke. Its soft capsule was approved in China in 2005, and its injection was approved...

May 2021 50 pages

Investigation Report on China's Dasatinib Market 2021-2025

US$ 2,600.00

Dasatinib, developed by Bristol-Myers Squibb, is an anti-tumor drug. It was first approved by the FDA in 2006 for the treatment of adult patients with Philadelphia chromosome-positive (Ph+) chronic my...

May 2021 50 pages

Investigation Report on China's Dolutegravir Market 2021-2025

US$ 2,600.00

Dolutegravir was developed by GlaxoSmithKline for the treatment of HIV-infected adults and children over 12 years old. Its product TIVICAY was approved in China in 2016 and was approved for children's...

May 2021 50 pages

Investigation Report on China's Esomeprazole Market 2021-2025

US$ 2,600.00

Esomeprazole is a proton pump inhibitor (PPI), which can effectively inhibit gastric acid secretion. It is clinically used to treat gastric acid-related diseases such as gastroesophageal reflux diseas...

May 2021 50 pages

Investigation Report on China's Golimumab Market 2021-2025

US$ 2,600.00

Golimumab is an immunosuppressive medication that can effectively regulate inflammation and bone metabolism. The trade name of Golimumab is SIMPONI, which was developed by Janssen Biologics BV. Its pr...

May 2021 50 pages

Investigation Report on China's Paclitaxel Market 2021-2025

US$ 2,600.00

Paclitaxel is a chemotherapeutic tumor drug used to treat metastatic breast cancer after failure of combination chemotherapy or relapse within 6 months after adjuvant chemotherapy. Its product, develo...

May 2021 50 pages

Investigation Report on China's Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (PEG-rhG-CSF) 2021-2025

US$ 2,600.00

Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (PEG-rhG-CSF) is an effective drug for the prevention and treatment of neutropenia or deficiency caused by tumor radiotherapy or chemo...

May 2021 50 pages

Investigation Report on China's Piperacillin and Tazobactam Market 2021-2025

US$ 2,600.00

Piperacillin and Tazobactam is a compound anti-infective drug composed of piperacillin (semi-synthetic penicillin antibiotic) and tazobactam (?-lactamase inhibitor). It is suitable for moderate and se...

May 2021 50 pages

Investigation Report on China's Propofol Market 2021-2025

US$ 2,600.00

Propofol is a short-acting intravenous anesthetic. Its uses include the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. It is als...

May 2021 50 pages

Investigation Report on China's Tiotropium Bromide Market 2021-2025

US$ 2,600.00

Tiotropium Bromide, developed by Boehringer Ingelheim International GmbH, is used to treat chronic obstructive pulmonary disease (COPD). Its product SPIRIVA was approved in China in 2006. In 2017, Tio...

May 2021 50 pages

Investigation Report on China's Tocilizumab Market 2021-2025

US$ 2,600.00

The trade name of Tocilizumab is ACTEMRA, which was developed by Roche Pharma (Schweiz) AG. In 2013, its product was firstly approved in China and its indication is RA. Tocilizumab was approved in Chi...

May 2021 50 pages

Investigation Report on China's Voriconazole Market 2021-2025

US$ 2,600.00

Voriconazole is used to treat progressive, potentially life-threatening fungal infections. Its product was developed by Pfizer. It was approved in China in 2004. By 2020, there are 11 manufacturers of...

May 2021 50 pages

Investigation Report on Chinese Compound Amino Acid Market 2021-2025

US$ 2,600.00

Compound Amino Acid is clinically used for patients with insufficient protein intake, malabsorption, and other amino acids that cannot meet the requirements of body metabolism. It was developed by Jap...

May 2021 50 pages

Global Antipsychotic Drugs Market Size study, Antipsychotic Drugs Market by Drug Class (First Generation, Second Generation, Third Generation and Others), by Application (Schizophrenia, Dementia, Bipolar and Unipolar Depression) and Regional Forecasts 2021-2027

US$ 3,000.00

Global Antipsychotic Drugs Market is valued approximately USD 12.67 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 1.95% over the forecast period 2021-2027. A “psyc...

May 2021 200 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1